Immunodeficient patients are less prone to develop serious complications
of COVID-19 and cytokine storm. However, they are more likely to develop
opportunistic infections that can mimic the symptoms of the SARS-CoV-2.
we presented a 27-year-old male case of SARS-CoV-2, who was complicated
with Pneumocystis jirovecii pneumonia, following treatment with
rituximab.